The researchers built three models: clinical (grade 1–2 endometrioid tumors by dilatation and curettage and less than 50% myometrial invasion on MRI without cervical infiltration), radiomics (selected radiomics features), and radiomics nomogram (combining selected radiomics features, myometrial invasion on MRI, and cancer antigen 125). This evidence concerns the gene MUC16 and endometrioid tumor.